OBD.L AI Price Prediction

Track OBD.L's AI-powered predictions, market trends, and investment insights.

OBD.L Sentiment OBD.L StockTwits OBD.L Reddit

Mock Tradesimulated, no real money

You don't hold OBD.L in your mock portfolio yet.

OBD.L AI Price Prediction

Track OBD.L's AI-powered predictions, market trends, and investment insights.

OBD.L Sentiment OBD.L StockTwits OBD.L Reddit

Evidence Stack

What Changed?

Key moves vs recent baseline (last day / last week)

Price (1d)-0.3%

Price (7d)-5.3%

Volume vs avg0.2x

Volatility vs normal0.3x

Why Now?

Plain-English summary of the biggest drivers (informational)

Risk Flags

Potential risk factors to review

Earnings in 7 days

Report expected before market open — expect volatility

Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.

Invalidation Signals

Reassess your thesis if any of these occur:

Price breaks below ~$0.16 (recent support level)

Earnings disappoint (report due 6/23/2026)

Upgrade to see the full Evidence Stack

What Changed, Why Now, and Risk Flags — available on the Investor plan and above

Get Started

OBD.L AI Stock Analysis

Financial Performance

bearish

The negative EPS and resulting negative P/E ratio indicate that Oxford BioDynamics Plc is currently loss-making and not generating positive net income. Without evidence of strong revenue growth or improving margins, the current financial profile points to ongoing profitability challenges and execution risk.

Negative EPS of -0.01 implies the company is not yet profitable at the net income level.
A P/E ratio of -0.18 reflects loss-making status and limits the usefulness of traditional valuation multiples for assessing upside.
Absent signs of accelerating revenue or margin expansion, the risk remains that additional capital may be needed before the business reaches sustainable profitability.

Stock Price & Technicals

bearish

At $0.18, the stock trades materially below its 200-day moving average of $0.31, confirming a pronounced downtrend. The 17.8% decline over the last month reinforces weak price momentum and suggests sentiment is currently negative, with the stock underperforming its own longer-term trend.

Current price of $0.18 is well below the 200-day moving average of $0.31, a classic technical sign of a sustained downtrend.
A 17.8% drop over the past month highlights strong negative momentum and potential ongoing selling pressure.
With no evidence of a base forming near the long-term average, technicals currently favor caution rather than a near-term reversal thesis.

Alternative Data Signals

neutral

Web traffic of roughly 9,965 visitors per month and modest growth across social channels suggest a small but slowly expanding digital footprint. However, the scale of engagement remains limited, and the absence of job openings points to either tight cost control or constrained growth investment, making these signals more neutral than clearly positive.

Estimated monthly web traffic of 9,965 visitors indicates relatively low but non-trivial awareness; no strong evidence of surging interest.
Social media followings are small but generally growing slightly (e.g., LinkedIn at 3,573 followers, up 0.8% in 90 days; Twitter/X at 476 followers, up 1.3%), suggesting gradual rather than explosive engagement.
Zero current job openings may indicate limited near-term expansion or hiring restraint, which tempers any bullish interpretation of the modest audience growth.

Conclusion

bearish

Overall, the combination of loss-making fundamentals, a sharply negative price trend, and only modest alternative data traction leads to a bearish stance on Oxford BioDynamics Plc at present. While incremental growth in online and social presence is a mild positive, it is not strong enough to offset the technical weakness and lack of profitability.

Loss-making status and a negative P/E, without clear evidence of accelerating growth, keep fundamental risk elevated.
The stock’s substantial discount to its 200-day moving average and recent 17.8% monthly decline signal entrenched negative momentum that outweighs the modestly improving alternative data signals.

AI Score

Hold

Alternative7

Fundamental2

Technical1

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.

Mock Tradesimulated, no real money

You don't hold OBD.L in your mock portfolio yet.